News and Updates for Healthcare Professionals

Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a foundation for the delivery of quality cardiovascular care.

With recent data demonstrating that lecanemab treatment can slow cognitive and functional decline in early symptomatic Alzheimer disease (AD), it is widely anticipated that this drug and potentially other monoclonal antibody infusions targeting amyloid-β protein will imminently be realistic options for some patients with AD.

The 2023 edition of our list features many first-time topics, and emphasis is on potential risks that could have the biggest impact on patients. The number one topic on this year’s lists has been steadily growing and was exacerbated by the COVID-19 pandemic: the pediatric mental health crisis.

People at high risk for nonalcoholic fatty liver disease (NAFLD), such as those with type 2 diabetes or medically complicated obesity, should be screened for advanced fibrosis, says new guidance from the American Association for the Study of Liver Diseases.

Pain is one of the most common reasons adults seek medical care in the United States. Acute pain, a nearly universal experience, is a physiologic response to noxious stimuli that can become pathologic.

Why CVD Risk Calculation Is So Important? Cardiovascular disease (CVD) is a leading cause of death for men and women across most racial and ethnic groups in the United States. The problem is immense: nearly two out of every three Americans will develop CVD in their lifetime and more than…

Everyone should receive safe and effective pain care. The Centers for Disease Control and Prevention (CDC) understands that treating patients living with pain can be complex and that treatment is highly individualized.

NIH-funded clinical trial underscores need for better treatments for deadly condition.

NIH findings may provide early clues about increased risks for advanced biological aging and premature death.

In the last of four blog posts on the challenges of advancing healthcare quality, members of AHRQ’s National Advisory Council highlight that little is known about the current quality of hospice care and how it varies across hospice programs. The authors assert that, as the population ages and older Americans…